Third Rock Ventures V, L.P.

Insider Reports History

Location: 29 Newbury Street, 3 Rd Floor, Boston, MA
Signature: /s/ Kevin Gillis, Chief Operating Officer of TRV GP V, LLC, general partner of Third Rock Ventures GP V, L.P., general partner of Third Rock Ventures V, L.P.
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Third Rock Ventures V, L.P.:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Rapport Therapeutics, Inc.	10%+ Owner	Common Stock	7.14M	$71.2M	$9.98	Jun 10, 2024	Direct
Septerna, Inc.	10%+ Owner	Common Stock	6.22M	$36.4M	$5.85	Oct 28, 2024	Direct
CARGO Therapeutics, Inc.	10%+ Owner	Common Stock	1.81M	$27.1M	$15.00	Nov 14, 2023	Indirect
CARGO Therapeutics, Inc.	10%+ Owner	Common Stock	1.74M	$26.1M	$15.00	Nov 14, 2023	Direct
Septerna, Inc.	10%+ Owner	Common Stock	3.15M	$18.4M	$5.85	Oct 28, 2024	Indirect
Rapport Therapeutics, Inc.	10%+ Owner	Common Stock	969K	$9.67M	$9.98	Jun 10, 2024	By Third Rock Ventures VI, L.P.
CARGO Therapeutics, Inc.	10%+ Owner	Series A-1 Preferred Stock	0			Nov 14, 2023	Direct
CARGO Therapeutics, Inc.	10%+ Owner	Series A-1 Preferred Stock	0			Nov 14, 2023	Indirect
Rapport Therapeutics, Inc.	10%+ Owner	Series A Preferred Stock	0			Jun 10, 2024	By Third Rock Ventures VI, L.P.
Rapport Therapeutics, Inc.	10%+ Owner	Series A Preferred Stock	0			Jun 10, 2024	Direct
Rapport Therapeutics, Inc.	10%+ Owner	Series B Preferred Stock	0			Jun 10, 2024	By Third Rock Ventures VI, L.P.
Septerna, Inc.	10%+ Owner	Series A Preferred Stock	0			Oct 28, 2024	Direct
Septerna, Inc.	10%+ Owner	Series B Preferred Stock	0			Oct 28, 2024	Indirect

Showing 1 to 13 of 13 entries

Insider Reports Filed by Third Rock Ventures V, L.P.

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
SEPN	Septerna, Inc.	Oct 28, 2024	6	$11.7M	4	Oct 28, 2024	10%+ Owner
SEPN	Septerna, Inc.	Oct 24, 2024	0	$0	3	Oct 24, 2024	10%+ Owner
RAPP	Rapport Therapeutics, Inc.	Jun 10, 2024	5	$0	4	Jun 10, 2024	10%+ Owner
RAPP	Rapport Therapeutics, Inc.	Jun 6, 2024	0	$0	3	Jun 6, 2024	10%+ Owner
CRGX	CARGO Therapeutics, Inc.	Nov 14, 2023	5	$20M	4	Nov 14, 2023	10%+ Owner
CRGX	CARGO Therapeutics, Inc.	Nov 9, 2023	0	$0	3	Nov 9, 2023	10%+ Owner